Log In
BCIQ
Print this Print this
 

SR16388

  Manage Alerts
Collapse Summary General Information
Company SRI International
DescriptionSteroidal anti-angiogenic molecule
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today